SIRT1 and cancer: Many studies, including those in humans, have reported that β-cryptoxanthin has cancer-preventing potential independently of other carotenoids and nutraceuticals, with many effects having an epigenetic outcome (e.g., SIRT1, microbiome, and other signaling pathways), apparently resulting from the molecule itself and not from its metabolization to retinoic acid [275].